Filana Therapeutics, Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Filana Therapeutics, Inc. (FLNA) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of $2.10 million for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-01.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-11-01
- Filana Therapeutics, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-09-30 was $0.00.
- Filana Therapeutics, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was $0.00, a 100.00% decline year-over-year.
- Filana Therapeutics, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was $2.10M.
- Filana Therapeutics, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was -$1.54M, a 271.56% decline year-over-year.
- Filana Therapeutics, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$2.17M.
- Filana Therapeutics, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$192.00K, a 116.38% decline from fiscal 2014.
- Filana Therapeutics, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was $1.17M, a 79.28% decline from fiscal 2013.
- Filana Therapeutics, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was $5.66M, a 67.90% decline from fiscal 2012.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $0.00 derived: sum of 2 quarters · filed 2017-11-01 | $2.10M 10-Q · filed 2017-11-01 | $557.00K derived: sum of 4 quarters · filed 2017-11-01 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $2.10M 10-Q · filed 2017-08-09 | $557.00K derived: sum of 3 quarters · filed 2017-08-09 | -$68.00K derived: sum of 4 quarters · filed 2017-11-01 |
| 2017-03-31 | $2.10M 10-Q · filed 2017-04-26 | $557.00K derived: sum of 2 quarters · filed 2017-04-26 | -$68.00K derived: sum of 3 quarters · filed 2017-11-01 | $1.43M derived: sum of 4 quarters · filed 2017-11-01 |
| 2016-12-31 | -$1.54M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-07 | -$2.17M derived: sum of 2 quarters · filed 2017-11-01 | -$669.00K derived: sum of 3 quarters · filed 2017-11-01 | -$2.17M 10-K · filed 2017-03-07 |
| 2016-09-30 | -$625.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $875.00K derived: sum of 2 quarters · filed 2017-11-01 | -$622.00K 10-Q · filed 2017-11-01 | $278.00K derived: sum of 4 quarters · filed 2017-11-01 |
| 2016-06-30 | $1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $3.00K 10-Q · filed 2017-08-09 | $903.00K derived: sum of 3 quarters · filed 2017-08-09 | $954.00K derived: sum of 4 quarters · filed 2017-08-09 |
| 2016-03-31 | -$1.50M 10-Q · filed 2017-04-26 | -$597.00K derived: sum of 2 quarters · filed 2017-04-26 | -$546.00K derived: sum of 3 quarters · filed 2017-04-26 | $505.00K derived: sum of 4 quarters · filed 2017-04-26 |
| 2015-12-31 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-07 | $951.00K derived: sum of 2 quarters · filed 2017-03-07 | $2.00M derived: sum of 3 quarters · filed 2017-03-07 | -$192.00K 10-K · filed 2017-03-07 |
| 2015-09-30 | $51.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-26 | $1.10M derived: sum of 2 quarters · filed 2016-10-26 | -$1.09M 10-Q · filed 2016-10-26 | $9.00K derived: sum of 4 quarters · filed 2017-03-07 |
| 2015-06-30 | $1.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-19 | -$1.14M 10-Q · filed 2016-07-19 | -$42.00K derived: sum of 3 quarters · filed 2017-03-07 | -$893.00K derived: sum of 4 quarters · filed 2017-03-07 |
| 2015-03-31 | -$2.19M 10-Q · filed 2016-05-05 | -$1.09M derived: sum of 2 quarters · filed 2017-03-07 | -$1.94M derived: sum of 3 quarters · filed 2017-03-07 | -$943.00K derived: sum of 4 quarters · filed 2017-03-07 |
| 2014-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-07 | $250.00K derived: sum of 2 quarters · filed 2017-03-07 | $1.25M derived: sum of 3 quarters · filed 2017-03-07 | $1.17M 10-K · filed 2017-03-07 |
| 2014-09-30 | -$851.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $150.00K derived: sum of 2 quarters · filed 2015-11-09 | $71.00K 10-Q · filed 2015-11-09 | $122.00K derived: sum of 4 quarters · filed 2016-03-03 |
| 2014-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-23 | $922.00K 10-Q · filed 2015-07-23 | $973.00K derived: sum of 3 quarters · filed 2016-03-03 | $974.00K derived: sum of 4 quarters · filed 2016-03-03 |
| 2014-03-31 | -$79.00K 10-Q · filed 2015-05-08 | -$28.00K derived: sum of 2 quarters · filed 2016-03-03 | -$27.00K derived: sum of 3 quarters · filed 2016-03-03 | $1.47M derived: sum of 4 quarters · filed 2016-03-03 |
| 2013-12-31 | $51.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03 | $52.00K derived: sum of 2 quarters · filed 2016-03-03 | $1.55M derived: sum of 3 quarters · filed 2016-03-03 | $5.66M 10-K · filed 2016-03-03 |
| 2013-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | $1.50M derived: sum of 2 quarters · filed 2014-11-05 | $5.61M 10-Q · filed 2014-11-05 | |
| 2013-06-30 | $1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06 | $5.60M 10-Q · filed 2014-08-06 | ||
| 2013-03-31 | $4.10M 10-Q · filed 2014-05-07 | |||
| 2012-12-31 | $17.62M 10-K · filed 2015-02-18 | |||
| 2011-12-31 | $59.90M 10-K · filed 2014-02-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |